Skip to main content
Kidney Transplant RejectionDiagnostics and screeningDiagnostic test

What this study is

Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.

What's being tested

  • MMDx

    Intervention · DIAGNOSTIC TEST

    Portion of kidney transplant indication biopsy

  • Prospera

    Intervention · DIAGNOSTIC TEST

  • HLA antibody

    Intervention · DIAGNOSTIC TEST

Both Prospera and HLA antibody

Transplant patient blood sample

Study details

Official title
Trifecta-Kidney cfDNA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology.
Sponsor
University of Alberta
Conditions
Kidney Transplant Rejection
Enrolling
300 people
Starts
2019-12-01
Est. completion
2029-12
Record
View on ClinicalTrials.gov ↗